Similarly, thioredoxin as a continuous variable was associated with an increased risk of HCC with an unadjusted OR of 1.45 (95% CI, 1.22–1.91; P < 0.001) when controls with LC and CLD were included. This evidence concerns the gene TXN and laryngotracheoesophageal cleft.